Ozeren, N. Et Al. 2012. CTNNB1 Mutation, beta-Catenin and E-Cadherin Expression and the Relationship with Clinical and Histopathological Prognostic Factors in Endometrial Adenocarcinomas and Hyperplasias. 101st Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) , (Vancouver, Canada).

Ozeren, N., GÜMÜRDÜLÜ, D., GÜZEL, B., Zeren, H., ERGİN, M., VARDAR, M. A., ... Altintas, A.(2012). CTNNB1 Mutation, beta-Catenin and E-Cadherin Expression and the Relationship with Clinical and Histopathological Prognostic Factors in Endometrial Adenocarcinomas and Hyperplasias . 101st Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), Vancouver, Canada

Ozeren, N. Et Al. "CTNNB1 Mutation, beta-Catenin and E-Cadherin Expression and the Relationship with Clinical and Histopathological Prognostic Factors in Endometrial Adenocarcinomas and Hyperplasias," 101st Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), Vancouver, Canada, 2012

Ozeren, N. Et Al. "CTNNB1 Mutation, beta-Catenin and E-Cadherin Expression and the Relationship with Clinical and Histopathological Prognostic Factors in Endometrial Adenocarcinomas and Hyperplasias." 101st Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) , Vancouver, Canada, 2012

Ozeren, N. Et Al. (2012) . "CTNNB1 Mutation, beta-Catenin and E-Cadherin Expression and the Relationship with Clinical and Histopathological Prognostic Factors in Endometrial Adenocarcinomas and Hyperplasias." 101st Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) , Vancouver, Canada.

@conferencepaper{conferencepaper, author={N. Ozeren Et Al. }, title={CTNNB1 Mutation, beta-Catenin and E-Cadherin Expression and the Relationship with Clinical and Histopathological Prognostic Factors in Endometrial Adenocarcinomas and Hyperplasias}, congress name={101st Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP)}, city={Vancouver}, country={Canada}, year={2012}}